Related Experiment Video
Updated: Aug 11, 2026

Impulsive Pressurization of Neuronal Cells for Traumatic Brain Injury Study
Published on: October 12, 2011
Calcium channel blockers for acute traumatic brain injury
J Langham1, C Goldfrad, G Teasdale
1R&D Public Health, Kensington, Chelsea and Westminster Health Authority, 50 Eastbourne Terrace, London, UK, W2 6LX. julia.langham@ha.kcw-ha.nthames.nhs.uk
Insights
Calcium channel blockers show uncertain effects for acute traumatic brain injury patients. However, nimodipine may benefit those with subarachnoid hemorrhage, despite potential adverse reactions.
Area of Science:
- Neuroscience
- Pharmacology
- Critical Care Medicine
Background:
- Acute traumatic brain injury (TBI) is a significant cause of mortality and long-term disability.
- Calcium channel blockers (CCBs) are investigated for mitigating secondary brain injury by preventing cerebral vasospasm and maintaining cerebral blood flow.
Purpose of the Study:
- To systematically evaluate the efficacy of calcium channel blockers in patients with acute traumatic brain injury.
- To assess the effects of CCBs in a specific subgroup of TBI patients with traumatic subarachnoid hemorrhage.
Main Methods:
- A comprehensive search of electronic databases and hand searching was conducted for randomized controlled trials (RCTs) up to October 1997.
- Eligibility criteria included RCTs involving patients with clinically diagnosed acute TBI of any severity.
- Data extraction and eligibility assessment were performed independently by two reviewers, with pooled odds ratios calculated using the Mantel-Haenszel method.
Main Results:
- Four eligible RCTs were identified. Overall, CCBs did not significantly reduce the risk of death (OR 0.91, 95% CI 0.70-1.17) or death/severe disability (OR 0.85, 95% CI 0.68-1.07).
- In the subgroup of patients with traumatic subarachnoid hemorrhage, CCBs showed a trend towards reduced risk of death (OR 0.59, 95% CI 0.37-0.94) and significantly reduced death or severe disability (OR 0.67, 95% CI 0.46-0.98).
Conclusions:
- The overall effect of calcium channel blockers in acute TBI remains uncertain due to limited evidence.
- Nimodipine demonstrated a potential beneficial effect in TBI patients with subarachnoid hemorrhage, but increased adverse events warrant careful consideration of its risk-benefit profile.
Background:
Acute traumatic brain injury is a major cause of death and disability. Calcium channel blockers have been used in an attempt to prevent cerebral vasospasm after injury, maintain blood flow to the brain and so prevent further damage.
Objectives:
To estimate the effects of calcium channel blockers in patients with acute traumatic brain injury and in a subgroup of brain injury patients with traumatic subarachnoid haemorrhage.
Search Strategy:
Hand searching and electronic searching for randomized controlled trials available by October 1997.
Selection Criteria:
Randomized controlled trials in patients with all levels of severity of clinically diagnosed acute traumatic brain injury.
Data Collection And Analysis:
Two reviewers (JL and CG) independently assessed the identified studies for eligibility and extracted data from each study. Summary odds ratios were calculated using the Mantel-Haenszel method.
Main Results:
Four RCTs were identified as eligible for inclusion in the systematic review. The effect of calcium channel blockers on the risk of death was reported in all RCTs. The pooled odds ratio for the four studies was 0.91 (95% confidence interval 0. 70 to 1.17). For the three RCTs that reported death and severe disability the pooled odds ratio was 0.85 (95% CI 0.68 to 1.07). In the two RCTs which reported the risk of death in a sub group of traumatic subarachnoid haemorrhage patients, the pooled odds ratio was 0.59 (95% CI 0.37 to 0.94). Three RCTs reported death and severe disability as an outcome in this subgroup, and the pooled odds ratio was 0.67 (95% CI 0.46 to 0.98).
Reviewer'S Conclusions:
This systematic review of randomized controlled trials of calcium channel blockers in acute traumatic head injury patients shows that considerable uncertainty remains over their effects. The effect of nimodipine in a subgroup of brain injury patients with subarachnoid haemorrhage shows a beneficial effect, though the increase in adverse reactions suffered by the intervention group may mean that the drug is harmful for some patients.
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Antihypertensive Drugs: Action of Calcium Channel Blockers
Transient Ischemic Attack l: Introduction
Traumatic Brain Injury l: Introduction
Cerebral Edema ll: Pathophysiology
Secondary Spinal Cord Injury llI: Pathophysiology

